Table of Contents Author Guidelines Submit a Manuscript
Experimental Diabetes Research
Volume 2012, Article ID 518426, 11 pages
http://dx.doi.org/10.1155/2012/518426
Research Article

A PEDF-Derived Peptide Inhibits Retinal Neovascularization and Blocks Mobilization of Bone Marrow-Derived Endothelial Progenitor Cells

1Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma, OK 73104, USA
2Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma, OK 73104, USA

Received 1 April 2011; Accepted 27 April 2011

Academic Editor: Gian Paolo Fadini

Copyright © 2012 Richard Longeras et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. J. Battegay, “Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects,” Journal of Molecular Medicine, vol. 73, no. 7, pp. 333–346, 1995. View at Google Scholar · View at Scopus
  2. N. Bouck, “PEDF: anti-angiogenic guardian of ocular function,” Trends in Molecular Medicine, vol. 8, no. 7, pp. 330–334, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Gao, Y. Li, D. Zhang, S. Gee, C. Crosson, and J. X. Ma, “Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization,” FEBS Letters, vol. 489, no. 2-3, pp. 270–276, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. J. W. Miller, A. P. Adamis, and L. P. Aiello, “Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy,” Diabetes Metabolism Reviews, vol. 13, no. 1, pp. 37–50, 1997. View at Publisher · View at Google Scholar · View at Scopus
  5. A. M. Abu El-Asrar, S. Struyf, H. Verbeke, J. Van Damme, and K. Geboes, “Circulating bone-marrow-derived endothelial precursor cells contribute to neovascularization in diabetic epiretinal membranes,” Acta Ophthalmologica, vol. 89, no. 3, pp. 222–228, 2011. View at Publisher · View at Google Scholar
  6. T. Asahara, T. Takahashi, H. Masuda et al., “VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells,” EMBO Journal, vol. 18, no. 14, pp. 3964–3972, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. D. G. Espinosa-Heidmann, A. Caicedo, E. P. Hernandez, K. G. Csaky, and S. W. Cousins, “Bone marrow-derived progenitor cells contribute to experimental choroidal neovascularization,” Investigative Ophthalmology and Visual Science, vol. 44, no. 11, pp. 4914–4919, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. W. Risau and I. Flamme, “Vasculogenesis,” Annual Review of Cell and Developmental Biology, vol. 11, pp. 73–91, 1995. View at Google Scholar · View at Scopus
  9. I. Flamme, T. Frölich, and W. Risau, “Molecular mechanisms of vasculogenesis and embryonic angiogenesis,” Journal of Cellular Physiology, vol. 173, no. 2, pp. 206–210, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. W. Risau, “Mechanisms of angiogenesis,” Nature, vol. 386, no. 6626, pp. 671–674, 1997. View at Google Scholar · View at Scopus
  11. S. P. Becerra, “Structure-function studies on PEDF: a noninhibitory serpin with neurotrophic activity,” Advances in Experimental Medicine and Biology, vol. 425, pp. 223–237, 1997. View at Google Scholar · View at Scopus
  12. D. W. Dawson, O. V. Volpert, P. Gillis et al., “Pigment epithelium-derived factor: a potent inhibitor of angiogenesis,” Science, vol. 285, no. 5425, pp. 245–248, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. E. T. H. Ek, C. R. Dass, and P. F. M. Choong, “PEDF: a potential molecular therapeutic target with multiple anti-cancer activities,” Trends in Molecular Medicine, vol. 12, no. 10, pp. 497–502, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Mori, E. Duh, P. Gehlbach et al., “Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization,” Journal of Cellular Physiology, vol. 188, no. 2, pp. 253–263, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. V. Stellmach, S. E. Crawford, W. Zhou, and N. Bouck, “Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 5, pp. 2593–2597, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Amaral and S. P. Becerra, “Effects of human recombinant PEDF protein and PEDF-derived peptide 34-mer on choroidal neovascularization,” Investigative ophthalmology & visual science, vol. 51, no. 3, pp. 1318–1326, 2010. View at Google Scholar · View at Scopus
  17. S. Filleur, K. Volz, T. Nelius et al., “Two functional epitopes of pigment epithelial-derived factor block angiogenesis and induce differentiation in prostate cancer,” Cancer Research, vol. 65, no. 12, pp. 5144–5152, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. L. E. H. Smith, E. Wesolowski, A. McLellan et al., “Oxygen-induced retinopathy in the mouse,” Investigative Ophthalmology and Visual Science, vol. 35, no. 1, pp. 101–111, 1994. View at Google Scholar · View at Scopus
  19. J. Azzarello, M. A. Ihnat, B. P. Kropp, L. A. Warnke, and H. K. Lin, “Assessment of angiogenic properties of biomaterials using the chicken embryo chorioallantoic membrane assay,” Biomedical Materials, vol. 2, no. 2, article 001, pp. 55–61, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Asahara, H. Masuda, T. Takahashi et al., “Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization,” Circulation Research, vol. 85, no. 3, pp. 221–228, 1999. View at Google Scholar · View at Scopus
  21. T. Asahara, T. Murohara, A. Sullivan et al., “Isolation of putative progenitor endothelial cells for angiogenesis,” Science, vol. 275, no. 5302, pp. 964–967, 1997. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Kobari, M. C. Giarratana, F. Pflumio, B. Izac, L. Coulombel, and L. Douay, “CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells,” Journal of Hematotherapy and Stem Cell Research, vol. 10, no. 2, pp. 273–281, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. T. S. Li, K. Hamano, M. Nishida et al., “CD117 stem cells play a key role in therapeutic angiogenesis induced by bone marrow cell implantation,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 285, no. 3, pp. H931–H937, 2003. View at Google Scholar · View at Scopus
  24. S. X. Zhang, J. J. Wang, G. Gao, K. Parke, and J. X. Ma, “Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy,” Journal of Molecular Endocrinology, vol. 37, no. 1, pp. 1–12, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Folkman, “Angiogenesis and apoptosis,” Seminars in Cancer Biology, vol. 13, no. 2, pp. 159–167, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Abe, T. Shimizu, S. I. Yamagishi et al., “Overexpression of pigment epithelium-derived factor decreases angiogenesis and inhibits the growth of human malignant melanoma cells in vivo,” American Journal of Pathology, vol. 164, no. 4, pp. 1225–1232, 2004. View at Google Scholar · View at Scopus
  27. J. A. Doll, V. M. Stellmach, N. P. Bouck et al., “Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas,” Nature Medicine, vol. 9, no. 6, pp. 774–780, 2003. View at Publisher · View at Google Scholar · View at Scopus